Experienced in Low Potassium Level

Laurent Papazian

Ap Hm
Marseille, FR 
Experienced in Low Potassium Level
Ap Hm
Marseille, FR 
OverviewLocationsClinical Research

Overview

Laurent Papazian practices in Marseille, France. Mr. Papazian is rated as an Experienced expert by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Pneumonia, COVID-19, Cerebral Hypoxia, and Lung Transplant.

His clinical research consists of co-authoring 248 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Low Potassium Level.

Gender
Male

Locations

AP HM
Marseille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
A Double-Blind, Randomized, Placebo-controlled Multicenter Trial of GRanulocyte-Macrophage Colony-stimulating Factor Administration to Decrease ICU Acquired Infections in Sepsis-induced ImmunoDepression
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Drug
Study Phase: Phase 3
C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19
C5a Receptor Expression in Circulating Myeloid Cells in ARDS Secondary to COVID-19
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Other
Study Phase: Not Applicable
Reduction of Mechanical Ventilation-induced Lesions During ARDS With Multimodal Ultra-protective Ventilation in Combination With ECMO
Reduction of Mechanical Ventilation-induced Lesions During ARDS With Multimodal Ultra-protective Ventilation in Combination With ECMO
Enrollment Status: Terminated
Publish Date: July 20, 2023
Intervention Type: Other
Study Phase: Not Applicable
Efficacy of a Preemptive Treatment by Ganciclovir or by Aciclovir in ICU Patients Requiring Prolonged Mechanical Ventilation and Presenting a Viral Replication (CMV and/or HSV) - Prospective, Randomized, Double-blinded Multicenter Trial
Efficacy of a Preemptive Treatment by Ganciclovir or by Aciclovir in ICU Patients Requiring Prolonged Mechanical Ventilation and Presenting a Viral Replication (CMV and/or HSV) - Prospective, Randomized, Double-blinded Multicenter Trial
Enrollment Status: Completed
Publish Date: April 06, 2023
Intervention Type: Drug
Study Drugs: Aciclovir, Ganciclovir
Study Phase: Phase 4
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Tailored Multicomponent Program for Discomfort Reduction in Critically il Patients May Decrease Post-traumatic Stress Disorder in General ICU Survivors at One Year
Enrollment Status: Unknown
Publish Date: March 23, 2022
Intervention Type: Other
Study Phase: Not Applicable
Bronchoalveolar Lavages in the Intensive Care Unit : Indications, Adverse Respiratory Effects, Contribution to Diagnosis and Therapy. A Multicenter, Prospective, Observational Study
Bronchoalveolar Lavages in the Intensive Care Unit : Indications, Adverse Respiratory Effects, Contribution to Diagnosis and Therapy. A Multicenter, Prospective, Observational Study
Enrollment Status: Completed
Publish Date: May 23, 2019
Intervention Type: Procedure
Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial
Impact of Nasal High-flow vs Venturi Mask Oxygen Therapy on Weaning Outcome: a Multicenter, Randomized, Controlled Trial
Enrollment Status: Completed
Publish Date: July 21, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

248 Total Publications

Correction: Heterogenous treatment effect of neuromuscular blocking agents for moderate-to-severe ARDS: a post hoc Markov model re-analysis of the ACURASYS trial.
Correction: Heterogenous treatment effect of neuromuscular blocking agents for moderate-to-severe ARDS: a post hoc Markov model re-analysis of the ACURASYS trial.
Journal: Intensive care medicine
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Papazian's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile